TP53 and neoplasm: Hence, resistance of hypoxic KRAS-mutant tumor cells to 3-BrPA through lower hMCT1 is likely to be antagonized by lower glucose uptake linked to diminished GLUT-1 transporter expression, a p53 function [59] now shown to be reactivated by Prima-1.